Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DermTech, Inc. - Common Stock
(NQ:
DMTK
)
0.0940
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DermTech, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
DermTech Appoints Two New Board Members
July 18, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases
July 06, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022
June 14, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech: Q4 Earnings Insights
↗
March 01, 2022
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech...
Via
Benzinga
Earnings Scheduled For March 1, 2022
↗
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Present at the William Blair Growth Stock Conference
June 01, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S.
May 24, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
May 18, 2022
From
DermTech, Inc.
Via
Business Wire
Looking Into DermTech's Return On Capital Employed
↗
May 13, 2022
Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter.
Via
Benzinga
DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
May 10, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
May 04, 2022
From
DermTech
Via
Business Wire
DermTech: Q1 Earnings Insights
↗
May 03, 2022
DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by...
Via
Benzinga
DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
May 03, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech's Earnings Outlook
↗
May 02, 2022
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will...
Via
Benzinga
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
April 28, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Expands Telehealth Application, DermTech Connect, Across 44 States
April 26, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
April 25, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Release Date for First-Quarter 2022 Financial Results
April 14, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2022
From
DermTech, Inc.
Via
Business Wire
Earnings Outlook For DermTech
↗
February 28, 2022
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
DermTech Management to Present at Upcoming Investor Conferences
February 24, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Welcomes Adelle Walker as Vice President of Consumer Products
February 23, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Announce Fourth Quarter and Full-Year Financial Results
February 15, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
January 31, 2022
From
DermTech, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
↗
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
63 Biggest Movers From Friday
↗
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis
November 29, 2021
From
DermTech, Inc.
Via
Business Wire
This Is the Main Problem With DermTech's Q3 Results
↗
November 20, 2021
Nothing major changed for the skin genomics company in Q3.
Via
The Motley Fool
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
